TwitterLinkedin

Contact Us

  • Biopharma Excellence
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistics and Data Sciences
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistics and Data Sciences
          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistics and Data Sciences
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR (Individual Safety Case Report) Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Post-Brexit Regulatory Support
            • Statistics and Data Sciences
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Career Opportunities
  • Training
Home > SMARTPHLEX > SMARTSEELVA – bioassay validation software

SMARTSEELVA

analytical method validation software, bioassay validation software, ICH Q2 compliant software, software for validation of bioassays

Your focus: bioassay validation

SMARTSEELVA is software that validates bioassays such as ELISA, RIA, parallel line, parallel curve, slope-ratio, microbiological assays, qPCR and many more.

Benefits

Value for you:

  • Standardize validation reporting across the organisation 
  • Always up-to-date and validated software, accessible from any location
  • Reduces report writing to a couple of minutes instead of days
  • Simple, even for non-statisticians!
  • Best-in-class decision making

Enables you to:

  • Compute the relative trueness, the precision and the accuracy of your bioassay (ELISA, RIA, parallel line, curve, slope-ratio, microbiological assays, qPCR and many more) and generate accuracy and linearity profiles
  • Content module: generate reports for the qualification or validation of bioassays which provide results expressed in concentration or quantity
  • Potency module: generate reports for the qualification or validation of relative potencies assays for which analytical results are assumed following a lognormal distribution
  • Define the optimal experimental design
  • Can be used for method optimization within QbD framework

Our statisticians provide support for any questions concerning the use of the software and the processing of your data.

Features

  • Use of Total Analytical Error (TAE) concept (i.e. combine bias and precision
  • Use of β-expectation Tolerance Interval to manage the risk in routine analysis, such as suggested in USP 1210
  • Generate an e-CTD report within minutes, in full compliance with authority expectations (ICH Q2, FDA, ISO, EMA, MHLW, USP 1210, USP 1220, USP 1225, ISO 17025, ISO 15189 and EDQM)
  • In compliance with ICH Q2(R2) (second revision) draft from 22-MAR-2022
  • Decision-making tool: one graph = one decision
  • Flexible variance component analysis (up to 5 factors)
  • Assessment of the format of the reportable value
  • Suitable for GxP use: fully validated according to the GAMP5 guidelines and 21 CFR part 11 compliant
  • 10 different statistical models proposed for calibration, easy selection thanks to the Accuracy Index:
    • Four Parameter Logistic Regression
    • Weighted (POM) Four Parameter Logistic Regression
    • Five Parameter Logistic Regression
    • Weighted (POM) Five Parameter Logistic Regression
    • Log-Log Regression
    • Power Regression
    • Weighted (POM) Power Regression
    • Quadratic Regression
    • Weighted (1/X) Quadratic Regression
    • Weighted (1/X2) Quadratic Regression
  • Software as a Service (SaaS) application:
    • no installation required: no need to validate the system on site
    • no maintenance costs
    • can be accessed from any location
    • always the latest version available, free of charge

To find out more or request a demonstration

CONTACT US

SMARTSEELVA – the details

For a quick overview of how SMARTSEELVA works, please check out our demo video >>

Request a Demo
Demo Version
Software Login

Related News

Are my (bio)pharmaceutical assay performances reliable? Only probability of success counts!
Are my (bio)pharmaceutical assay performances reliable? Only probability of success counts!
14th September 2021
PharmaLex Global Statistics and Data Science Team announced as winner by BookAuthority
PharmaLex Global Statistics and Data Science Team announced as winner by BookAuthority
16th August 2021
Log or not log (transform data) that’s the question
Log or not log (transform data) that’s the question
1st July 2021

Related Resources

Thought Leadership

  • Why you never really validate your analytical method unless you use the total error approach (part II: Producer and Consumer risks)
  • Why you never really validate your analytical method unless you use the total error approach (part I: concept)
  • New SAS solutions for Population PK Model
  • Bayesian Power, Assurance and Probability of Success: Reproducibility Issues
  • Bayesian Power, Assurance and Probability of success: A quick who’s who
  • Proposal for a Single Arm Clinical Study in Rare Disease using Bayesian Statistics

Case Studies

  • Data Science long-term support to a global submission dossier
  • Tolerance intervals solution
  • Setting calibration frequency for an IVD
  • Preparing for process characterization activities
  • Setup an Atlassian product (Jira, confluence)
  • Validation of SoftMaxPro
  • Development and Implementation of the Robustness Index
  • Implementing parallelism tests in JMP
  • Continuous Manufacturing: Development, Optimization and Validation
  • Biosimilarity assessment on multiple CQAs
  • Bayesian modelling and prediction of patient recruitment
  • Automatic detection of disease events based on accelerometer data
  • Analytical Method Comparisons
  • Acceptance criteria for Bioassay validation
  • Computer Software Validation for Multinational Pharmaceutical Company

Webinars

  • Bayesian Approaches for Incorporating Natural History Data in Studies of Rare and Pediatric Disease
  • Bayesian Adaptive Approaches in Rare and Pediatric Disease
  • Software Suite for the Life Cycle of Analytical Methods & Bioassays: Gain Trust in your Results
  • Introduction to Bayesian Methodologies in CMC
  • Good Statistical Practices - Discovery to Clinical Research

Video & Animation

  • Using Bayesian Statistics for Clinical Research

Related Services

  • Custom Software Development
  • Lab Tools
  • SMARTENOVAL – analytical method validation software
  • SMARTSTABELITY – product stability and shelf-life estimation software
  • SMARTSTATS – statistical report writing
  • SMARTTRANSVAL – analytical method transfer software
  • Statistical Training
  • Statistics and Data Sciences
  • Statistics Software Login
Biopharma Excellence Website Image

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

Visit Website
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
pharmalexglobal PharmaLex @pharmalexglobal ·
12h

Join our webinar to learn more about 👉 Integrated product development for new osteoarthritis treatments on September 20, 4-5 PM CET

Register now: https://go.pharmalex.com/pharmalex-webinar-integrated-product-development-osetoarthritis-treatments?utm_source=SocialMedia&utm_medium=Webinar&utm_campaign=IPD

COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • Highly competent, knowledgeable, absolutely reliable and dedicated to the projects

    Europe based medium-sized biotech development company
    Senior Director
PharmaLex
©2022 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit LogoSGS Logo

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team

    Please DO NOT send us event/conference information.
    We will not respond and these will be deleted immediately.





    Select your state:

    .
    If you do not wish to receive any communication from us, you may unsubscribe at any time.





      Select your state:

      .
      You can unsubscribe at any time at data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      #AskTheExpert #TogetherBEYONDCOVID19





        Select your state:

        .
        You can unsubscribe at any time at data.protection@pharmalex.com

        If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

        #TogetherBEYONDCOVID19

        We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for